The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Abeona Therapeutics Inc COM 00289Y107 37,756 2,359,767 SH   SOLE   2,359,767 0 0
Advaxis Inc. W EXP 07/15/201 007624117 20 112,500 SH   SOLE   112,500 0 0
Aldeyra Therapeutics Inc COM 01438T106 987 124,096 SH   SOLE   124,096 0 0
Ampio Pharmaceuticals Inc. COM 03209T109 5,710 2,595,484 SH   SOLE   2,595,484 0 0
Anavex Life Sciences Corp COM NEW 032797300 1,897 724,205 SH   SOLE   724,205 0 0
Biohaven Pharmactl Hldg Co L COM G11196105 29,633 749,815 SH   SOLE   749,815 0 0
Catasys Inc COM 149049504 61 9,081 SH   SOLE   9,081 0 0
Chromadex Corp COM NEW 171077407 178 47,866 SH   SOLE   47,866 0 0
Corbus Pharmaceuticals HLDGS COM 21833P103 19,765 3,913,874 SH   SOLE   3,913,874 0 0
Eiger Biopharmaceuticals Inc COM 28249U105 918 75,238 SH   SOLE   75,238 0 0
Electrocore Inc COM 28531P103 6,551 396,825 SH   SOLE   396,825 0 0
Entera Bio Ltd SHS M40527109 2,996 475,540 SH   SOLE   475,540 0 0
Evoke Pharma Inc COM 30049G104 688 275,000 SH   SOLE   275,000 0 0
Galmed Pharmaceuticals Ltd SHS M47238106 2,499 210,000 SH   SOLE   210,000 0 0
Krystal Biotech Inc COM 501147102 4,461 300,000 SH   SOLE   300,000 0 0
Lipocine Inc New COM 53630X104 65 50,000 SH   SOLE   50,000 0 0
Soligenix Inc. COM 834223307 813 837,800 SH   SOLE   837,800 0 0
Vascular Biogenics LTD COM M96883109 1,973 896,771 SH   SOLE   896,771 0 0
Volition RX LTD COM 928661107 703 351,538 SH   SOLE   351,538 0 0